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abstract
 
Phosphodiesterases (PDEs) catalyze the hydrolysis of the second messengers cAMP and cGMP. How-
ever, little is known about how PDE activity regulates cyclic nucleotide signals in vivo because, outside of special-
ized cells, there are few methods with the appropriate spatial and temporal resolution to measure cyclic nucle-
otide concentrations. We have previously demonstrated that adenovirus-expressed, olfactory cyclic nucleotide–
gated channels provide real-time sensors for cAMP produced in subcellular compartments of restricted diffusion
near the plasma membrane (Rich,
 
 
 
T.C., K.A. Fagan, H. Nakata, J. Schaack, D.M.F. Cooper, and J.W. Karpen. 2000.
 
J. Gen. Physiol.
 
 116:147–161). To increase the utility of this method, we have modiﬁed the channel, increasing both
 
its cAMP sensitivity and speciﬁcity, as well as removing regulation by Ca
 
2
 
 
 
-calmodulin. We veriﬁed the increased
sensitivity of these constructs in excised membrane patches, and in vivo by monitoring cAMP-induced Ca
 
2
 
 
 
 inﬂux
through the channels in cell populations. The improved cAMP sensors were used to monitor changes in local
cAMP concentration induced by adenylyl cyclase activators in the presence and absence of PDE inhibitors. This
approach allowed us to identify localized PDE types in both nonexcitable HEK-293 and excitable GH4C1 cells. We
have also developed a quantitative framework for estimating the K
 
I
 
 of PDE inhibitors in vivo. The results indicate
that PDE type IV regulates local cAMP levels in HEK-293 cells. In GH4C1 cells, inhibitors speciﬁc to PDE types I
and IV increased local cAMP levels. The results suggest that in these cells PDE type IV has a high 
 
K
 
m
 
 for cAMP,
whereas PDE type I has a low 
 
K
 
m
 
 for cAMP. Furthermore, in GH4C1 cells, basal adenylyl cyclase activity was readily
observable after application of PDE type I inhibitors, indicating that there is a constant synthesis and hydrolysis of
cAMP in subcellular compartments near the plasma membrane. Modulation of constitutively active adenylyl cy-
clase and PDE would allow for rapid control of cAMP-regulated processes such as cellular excitability.
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INTRODUCTION
 
Cyclic nucleotide phosphodiesterases (PDEs),* the cru-
cial terminators of cAMP and cGMP signals, were dis-
covered almost 40 yr ago (Drummond and Perrot-Yee,
1961). Since then, PDEs have been classiﬁed into
eleven families according to substrate speciﬁcity, regu-
lation, pharmacology, and, more recently, amino acid
homology (Beavo, 1988, 1995; Conti et al., 1995). Stud-
ies have conﬁrmed differential regulation of PDE fami-
lies by Ca
 
2
 
 
 
-calmodulin (CaM), G-proteins, phosphory-
lation, and cyclic nucleotides. The diversity of PDE fam-
ilies has led to the realization that PDE activity is a
central element in the control of second messenger sig-
naling, as important as adenylyl and guanylyl cyclase ac-
tivity in shaping cyclic nucleotide signals. Yet, little is
known about how PDE regulates cyclic nucleotide sig-
nals in vivo or how cyclic nucleotide signals differen-
tially regulate hundreds of cellular targets because, out-
side of specialized cells, there are few convenient real-
time measures of cyclic nucleotide concentration.
Retinal rod outer segments are the most closely ex-
amined second messenger signaling system, in part, be-
cause the endogenous CNG channels have been used
as real-time detectors of cGMP concentration (Baylor
et al., 1979). Information from biochemical measure-
ments of guanylyl cyclase and cGMP-speciﬁc PDE have
been combined with real-time measurements of cGMP
concentration to characterize the relationship between
these enzymes in regulating cGMP levels (Fung et al.,
1981; Koch and Stryer, 1988; Gorczyca et al., 1994;
Koutalos et al., 1995a,b; He, W., et al., 1998; Tsang et
al., 1998; Chen et al., 2000; Leskov et al., 2000; Nikonov
et al., 2000). The convergence of different approaches
has led to an unprecedented understanding of feed-
back signaling within this model system (for review see
Stryer, 1991; Lagnado and Baylor, 1992; Pugh and
Lamb, 1993; Yarﬁtz and Hurley, 1994; Yau, 1994; Polans
et al., 1996; Pugh et al., 1997; Molday, 1998).
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Abbreviations used in this paper:
 
 AC, adenylyl cyclase; AKAP, A-kinase
anchoring protein; CaM, calmodulin; HEK-293, human embryonic
kidney cell line; IBMX, 3-isobutyl-1-methylxanthine; NO, nitric ox-
 
ide; pCPT-cGMP, 8-
 
p
 
-chlorophenylthio-cGMP; PDE, phospho-
diesterase; RO-20-1724, 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidi-
none; VIP, vasoactive intestinal peptide; WT, wild-type. 
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PDE Activity Monitored Using CNG Channels as cAMP Biosensors
 
We recently reported that cAMP concentration can
be measured accurately with the rat wild-type (WT) ol-
factory CNG channel, encoded by an adenovirus vector
(Rich et al., 2000). An important ﬁnding in multiple
cell types was that cAMP is produced in subcellular
compartments near the plasma membrane. Diffusion
between these compartments and the bulk cytosol is se-
verely restricted. These regions likely allow for rapid
and energetically efﬁcient activation of cAMP-depen-
dent processes, and may help to explain how cAMP can
differentially regulate large numbers of cellular targets.
In this study, we have modiﬁed the WT CNG channel to
increase its sensitivity and speciﬁcity for cAMP and to
remove regulation by Ca
 
2
 
 
 
-CaM. We also present a con-
venient, optical method for detecting changes in cAMP,
taking advantage of the Ca
 
2
 
 
 
 permeability of the chan-
nel. Using the modiﬁed CNG channels, this assay is sen-
sitive to cAMP in the physiologic range (0.1–50 
 
 
 
M).
We have used this approach to probe the interactions
between adenylyl cyclase (AC) and PDE in regulating
local cAMP concentration in two cell types, nonexcit-
able HEK-293 and excitable GH4C1 pituitary cells.
 
MATERIALS AND METHODS
 
Construction of CNG Channel–encoding Adenoviruses
 
Point mutations were introduced into the 
 
 
 
 subunit of the WT rat
olfactory CNG channel (CNG2, CNC
 
 
 
3) using the QuikChange
site-directed mutagenesis kit (Stratagene). Overlap extension PCR
was used to delete the Ca
 
2
 
 
 
-CaM binding site (amino acids 61–90).
A replication-defective adenovirus, in which the channel coding
sequence containing the E583M mutation replaced the E1 region,
was constructed as described previously (Fagan et al., 1999).
Brieﬂy, the cDNA encoding the mutant channel was ligated into
the plasmid pACCMV (Gomez-Foix et al., 1992) under the control
of the cytomegalovirus major immediate early (CMV) promoter
between the BamHI and SalI sites. The plasmid was then digested
with SalI and ligated with a BstBI adaptor. The resultant plasmid
was then digested with BstBI and XmnI and ligated with BstBI-
digested Ad5
 
dl
 
327
 
Bst
 
 
 
-gal-terminal-protein complex, that had
been isolated by banding puriﬁed Ad5
 
dl
 
327
 
Bst
 
 
 
-gal (Schaack et al.,
1995) virions in 2.8 M CsCl, and 4 M guanidine-HCl. The ligation
products were used to transfect HEK-293 cells using Ca
 
3
 
(PO
 
4
 
)
 
2
 
precipitation (Jordan et al., 1996). The transfected cells were incu-
bated for 7 d. The cells were frozen and thawed to release the vi-
rus, and dilutions were used to infect HEK-293 plates for plaque
puriﬁcation. The infected HEK-293 plates were overlaid with me-
dium in Noble agar, fed after 4 d, and stained with X-gal (5-
bromo-4-chloro-3-indolyl-
 
 
 
-
 
d
 
-galactopyranoside) and neutral red.
Clear plaques, which were derived from viral chromosomes lack-
ing the LacZ gene of the parental virus, were ampliﬁed and ana-
lyzed by PCR and restriction digestion for the presence of the mu-
tated CNG channel cDNA.
Adenovirus transducing vectors encoding C460W/E583M and
 
 
 
61–90/C460W/E583M channels were constructed using the
AdEasy system (He, T.-C., et al., 1998). The cDNA encoding the
mutant channel was ligated into pShuttle-CMV between the KpnI
and XbaI sites. The resultant plasmid was linearized by digestion
with PmeI and used to transform 
 
Escherichia coli
 
 strain BJ5183
that had been transformed with pAdEasy-1. A plasmid containing
the adenovirus chromosome encoding the mutated CNG chan-
 
nel was digested with PacI to release the adenovirus chromo-
some, and this DNA was used to transfect HEK-293 cells. After in-
cubation for 7 d, the virus was released by freezing and thawing,
and plaque puriﬁed. The puriﬁed virus was tested for the pres-
ence of the CNG channel cDNA by PCR. A virus containing the
channel cDNA was grown in large scale in HEK-293 cells and pu-
riﬁed by banding using CsCl step and isopycnic gradients.
 
Cell Culture and Channel Expression
 
HEK-293 cells were maintained in culture and infected with ade-
novirus as described previously (Rich et al., 2000). Brieﬂy, HEK-
293 cells were maintained in MEM (Life Technologies Inc.) sup-
plemented with 26.2 mM NaHCO
 
3
 
, 10% (vol/vol) FBS (Gemini),
penicillin (50 
 
 
 
g/ml), and streptomycin (50 
 
 
 
g/ml), pH 7.0, at
37
 
 
 
C in a humidiﬁed atmosphere of 95% air and 5% CO
 
2
 
. Cells
were plated at 
 
 
 
60% conﬂuence in 100-mm culture dishes 24 h
before infection with the CNG channel–encoding adenovirus
constructs (multiplicity of infection 
 
 
 
 10 plaque forming units
per cell). 2 h after infection, hydroxyurea was added to the cell
media at 2 mM ﬁnal concentration to partially inhibit viral repli-
cation. 24 h after infection cells were detached with PBS contain-
ing 0.03% EDTA, resuspended in serum-containing medium,
and assayed within 12 h.
GH4C1 rat pituitary cells (American Type Culture Collection)
were maintained in 13 ml Ham’s F-10 medium (Life Technologies
Inc.) supplemented with 14.3 mM NaHCO
 
3
 
, 15% donor horse se-
rum (Gemini), and 2.5% FBS, pH 6.8, in 75-cm
 
2
 
 ﬂasks at 37
 
 
 
C in a
humidiﬁed atmosphere of 95% air and 5% CO
 
2
 
. Cells were split
weekly (1:4) and washed with fresh medium twice weekly. Cells
were plated at 
 
 
 
60% conﬂuence in 100-mm culture dishes 24 h
before infection with the CNG channel–encoding adenovirus con-
structs (multiplicity of infection 
 
 
 
 50 plaque forming units per
cell). 48 h after infection cells were detached, resuspended in se-
rum-containing medium, and assayed within 12 h.
 
Electrical Recording
 
To assess the cyclic nucleotide sensitivity of different CNG chan-
nel constructs, excised, inside-out patch recordings were made at
room temperature (20–21
 
 
 
C) using an Axopatch-200A patch-
clamp ampliﬁer (Axon Instruments Inc.). Pipettes were pulled
from borosilicate glass and heat polished. Pipettes were lowered
onto the cells and gigaohm seals were formed. Patches were ex-
cised by shearing cells from the pipette with a jet of liquid. Ionic
currents were elicited by 250-ms pulses to membrane potentials
of 
 
 
 
50 and 
 
 
 
50 mV from a holding potential of 0 mV. Current
records were sampled at ﬁve times the ﬁlter setting and stored on
an IBM compatible computer. Records were corrected for errors
due to series resistance (pipette resistance was 4.1 
 
 
 
 0.1 M
 
 
 
).
Both the pipette and bath solutions contained the following (in
mM): 130 NaCl, 2 HEPES, 0.02 EDTA, and 1 EGTA, pH 7.6. Cy-
clic nucleotide–induced currents were obtained from the differ-
ence between currents in the presence and absence of cyclic nu-
cleotides. Dose–response curves for cAMP and cGMP were ob-
tained at 
 
 
 
50 and 
 
 
 
50 mV in the same patch. The effects of the
modiﬁcations were assessed using the Hill equation, I/I
 
max
 
 
 
 
 
[cNMP]
 
N
 
/([cNMP]
 
N 
 
  
 
K
 
1/2
N
 
), where I/I
 
max
 
 is the fraction of
maximal current, cNMP represents cyclic nucleotide, 
 
K
 
1/2
 
 is the
concentration that gives half-maximal current, and 
 
N
 
 is the Hill
coefﬁcient, an index of cooperativity.
 
Detection of cAMP in Populations of Cells
 
Homomultimeric CNG channels comprised of the rat olfactory
channel 
 
 
 
 subunit are permeable to Ca
 
2
 
 
 
 (Frings et al., 1995). We
have taken advantage of this to detect changes in local cAMP con- 
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centration. In this assay, an increase in local cAMP concentration
causes activation of CNG channels and a subsequent increase in
Ca
 
2
 
 
 
 entry (Rich et al., 2000). Thus, a change in the rate of Ca
 
2
 
 
 
inﬂux in response to a stimulus reﬂects a change in the cAMP
level. In this study, cAMP synthesis was stimulated using either for-
skolin or agonists of G-protein–coupled receptors. PDE activity
was assessed using a variety of type-speciﬁc PDE inhibitors. Certain
ones inhibit multiple PDE types; the efﬁcacies and speciﬁcities of
the inhibitors used in this study are listed in Table I.
We used the ﬂuorescent indicator fura-2 to monitor Ca
 
2
 
 
 
 in-
ﬂux in cell populations. Cells were loaded with 4 
 
 
 
M fura-2/AM
(the membrane-permeant form) and 0.02% pluronic F-127 at
room temperature for 30–40 min (HEK-293 cells) or 70 min
(GH4C1 cells), in a buffer containing Ham’s F-10 medium sup-
plemented with 1 mg/ml BSA fraction V (BSA, Fisher) and 20
mM HEPES, pH 7.4. In some experiments, HEK-293 cells were
loaded with a higher concentration of fura-2/AM (16 
 
 
 
M) for
comparison (see below). Cells were washed twice, then resus-
pended in a solution containing the following (in mM): 145
NaCl, 11 
 
d
 
-Glucose, 10 HEPES, 4 KCl, 1 CaCl
 
2
 
, 1 MgCl
 
2
 
, and 1
mg/ml BSA, pH 7.4 (3–4 
 
  
 
10
 
6
 
 cells /3 ml buffer solution), and
assayed using an LS-50B spectroﬂuorimeter (Perkin Elmer). Ad-
ditions were made by pipetting stock solutions into a stirred cu-
vette. The mixing time was estimated to be on the order of 5 s.
Fluorescence was measured at an excitation wavelength of 380
nm and an emission wavelength of 510 nm. Under these condi-
tions, Ca
 
2
 
 
 
 inﬂux causes a decrease in ﬂuorescence (
 
 
 
F), which
was expressed relative to the pre-stimulus ﬂuorescence (F
 
0
 
) to
correct for variations in dye concentration, and to allow for com-
parison of results on different batches of cells. Data were sam-
pled at 0.5 Hz and ﬁltered at 0.1 Hz (see Fig. 3, A and B) or sam-
pled at 6 Hz and ﬁltered at 1.2 Hz (see Fig. 3, C and D).
The measurement of absolute Ca
 
2
 
 
 
 inﬂux rates using ﬂuores-
cence requires that fura-2 overwhelm endogenous Ca
 
2
 
 
 
 buffers,
and that the relation between ﬂuorescence changes and Ca
 
2
 
 
 
 en-
try be known (Schneggenburger et al., 1993; Frings et al., 1995).
However, in this study, we are concerned with relative Ca
 
2
 
 
 
 inﬂux
rates, which report changes in cAMP levels. This requires only
that fura-2 detect a ﬁxed proportion of the entering Ca
 
2
 
 
 
 in a
given experiment. For this to be true, the concentration of un-
bound fura-2 should not change appreciably upon Ca
 
2
 
 
 
 binding,
and cellular Ca
 
2
 
 
 
 buffers that are not overwhelmed by fura-2
should also not be signiﬁcantly depleted by Ca
 
2
 
 
 
 binding. Under
these conditions, the equilibrium concentration of Ca
 
2
 
 
 
-bound
fura-2 (CaF), monitored by ﬂuorescence at 380 nm, is given by:
 
(1)
 
where F represents fura-2, K
 
F
 
 the dissociation constant for Ca
 
2
 
 
 
binding to fura-2, B the endogenous buffer, K
 
B
 
 the dissociation
constant for Ca
 
2
 
 
 
 binding to the endogenous buffer, and Ca
 
T
 
 the
total Ca
 
2
 
 
 
 concentration that freely exchanges between fura-2
and the endogenous buffer. The equilibrium assumption is rea-
sonable given the time scale of the experiments presented here
(tens to hundreds of seconds) and the time scale of binding and
unbinding of Ca
 
2
 
 
 
 from fura-2 and endogenous buffers (millisec-
onds). Eq. 1 indicates that with [F] and [B] unchanged by the
binding of Ca
 
2
 
 
 
, [CaF] will be a constant fraction of [Ca
 
T
 
], and
therefore directly proportional to the amount of entering Ca
 
2
 
 
 
.
In experiments in which quantitative information was extracted
(e.g., the in vivo estimate of K
 
I
 
 for PDE inhibitors), we purposely
worked at low levels of Ca
 
2
 
 
 
 inﬂux. A typical experiment is shown
in Fig. 1, in which addition of 0.5 
 
 
 
M forskolin (an adenylyl cy-
clase activator) and 50 nM rolipram (a PDE inhibitor) caused a
rise in cAMP and an increase in Ca
 
2
 
 
 
 inﬂux. There are several
lines of evidence that free fura-2 levels did not change signiﬁ-
cantly at these low inﬂux rates, and that depletion of endoge-
nous buffers did not distort the measurements. First, after a brief
delay (during which cAMP rose to steady level), the Ca
 
2
 
 
 
 inﬂux
rate was constant for a substantial period (linear ﬁt in Fig. 1).
Second, the changes in ﬂuorescence over which Ca
 
2
 
 
 
 inﬂux rates
were measured were always a very small fraction of the total
change in ﬂuorescence measured when saturating Ca
 
2
 
 
 
 was ad-
mitted into the cells (by adding 30 
 
 
 
l of 10% Triton to the cu-
CaF []
CaT []
1
KF
F []
--------
KF
F []
-------- B []
KB
-------- ⋅ ++
--------------------------------------------- , =
TABLE I
Specificity of PDE Inhibitors for Different PDE Families
Inhibitor
Reported
specificity I II III IV V VI VII VIII IX X XI
IBMX3,6,8,10–12,15,16,20–22 nonselective 2–3 20–50 2 5–15 4–7 10 2–8  200  200 2.6 49.8
8-methoxymethyl-IBMX2,4,14,15 PDE I 2–8 69  100
EHNA12,16,18–22 PDE II 0.5–1  500  100  100  100 69
Trequinsin23 PDE III 0.5–2 0.0003
Quazinone13 PDE III 0.6
Etazolate1 PDE IV 2
RO-20-17247,9,12,20,21,23 PDE IV 200  100 52 1–2 250  200  200
Rolipram5,8,9,15–17,20–23 PDE IV  150  100 0.05–2  100  100  200  200 47  100
Zaprinast6,8,9,15,16,20–22 PDE V–VI 3–10 70 10 22 0.2–0.5 0.15  50  100 29–35 11 12
There are over 30 known forms of PDE that have been grouped into 11 families. Of these families, PDE types V, VI, and IX are cGMP-specific. The IC50 of
PDE inhibitors given in  M. Recently, an isoform of PDE type IV, PDE4A, purified from U937 monocytic cells was shown to be inhibited by rolipram with
an IC50 of 3 nM (MacKenzie and Houslay, 2000). It should be noted that these efficacies may be modulated in vivo. For example, it has been shown that
forms of PDE type IVA are  10-fold more sensitive to rolipram when they bind to the SRC family tyrosyl kinase LYN (McPhee et al., 1999). Data were
obtained using heterologously expressed mouse (types VII, VIII, and X) and human (types I, II, IV, V, VII, IX, and XI) PDEs as well as endogenous PDEs
from dog kidney (type IV), rat brain (type IV), bovine heart (types III and IV), human heart (type II), bovine aorta (types I, III, and V), rabbit aorta (types
I, IV, and V), and bovine photoreceptor (type VI). Data compiled from: 1(Ahluwalia and Rhoads, 1982), 2(Ahn et al., 1989), 3(Beavo, 1988), 4(Bolger et
al., 1993), 5(Bolger et al., 1997), 6(Coste and Grondin, 1995), 7(Epstein et al., 1982), 8(Fawcett et al., 2000), 9(Fisher et al., 1998), 10(Gardner et al., 2000),
11(Harrison et al., 1988), 12(Hetman et al., 2000), 13(Holck et al., 1984), 14(Lorenz and Wells, 1983), 15(Loughney et al., 1996), 16(Loughney et al., 1998),
17(Nemoz et al., 1985), 18(Podzuweit et al., 1995), 19(Rosman et al., 1997), 20(Soderling et al., 1998a), 21(Soderling et al., 1998b), 22(Soderling et al., 1999),
23(Whalin et al., 1991). Blank spaces indicate that data are not available.66 PDE Activity Monitored Using CNG Channels as cAMP Biosensors
vette). The ﬂuorescence changes used in the linear ﬁts were gen-
erally  10% of the saturated fura-2 response, indicating that un-
bound fura-2 was predominant. At high levels of Ca2  inﬂux,
nonlinearities in the traces are likely due to depletion of fura-2
and Ca2  pumping mechanisms. Third, increasing the external
fura-2/AM concentration from 4 to 16  M signiﬁcantly altered
the intracellular fura-2 concentration but had no effect on the
measurement of relative Ca2  inﬂux rates or estimates of PDE in-
hibitor KI. The intracellular concentrations of fura-2 were not
determined, but a previous study of neuroblastoma cells and
isolated pulmonary artery endothelial cells found that 60 min
loading with 10  M fura-2/AM yielded intracellular fura-2 con-
centrations of  130  M (Oakes et al., 1988). If HEK-293 cells be-
have similarly, we would expect intracellular concentrations of 35
and 140  M under the two loading conditions.
Neher and Augustine (1992) have shown in adrenal chromaf-
ﬁn cells that 98–99% of entering Ca2  binds to endogenous buff-
ers that are present at high concentration (375–750  M) but have
a low afﬁnity for Ca2  (KB  5–10  M). Thus, the ratio [B]/KB in
Eq. 1 was estimated to be 75. KF for fura-2 was estimated to be 150
nM. Thus, the [F]/KF values under our two loading conditions
are expected to be 233 and 933. At the higher loading condition,
fura-2 may be overwhelming the low afﬁnity cellular buffers. How-
ever, as pointed out above, this is not necessary as long as the buff-
ers are not being depleted. It is very likely that low afﬁnity buffers
are present at a high enough concentration that they are not be-
ing depleted by the low amounts of entering Ca2 . Two of the
lines of evidence cited above indicate that buffers (including any
high afﬁnity buffers that may be present) are not affecting the
proportion of Ca2  detected by fura-2: the linearity of the inﬂux
traces (Fig. 1) and the observation that increasing fura-2 by a fac-
tor of four does not alter the measurement of relative Ca2  inﬂux
rates. These results strongly suggest that any high afﬁnity buffers
are being overwhelmed by the fura-2 concentrations used.
Unless otherwise stated, data are representative of four experi-
ments, and quantiﬁed results are given as mean   standard er-
ror. Forskolin, VIP, nimodipine, and PDE inhibitors were ob-
tained from Calbiochem. Fura-2/AM and pluronic F-127 were
purchased from Molecular Probes. Unless otherwise noted, all
other chemicals were obtained from Sigma-Aldrich.
RESULTS
Improving the cAMP-sensing Capabilities of CNG Channels
We have previously shown that adenovirus-expressed
rat olfactory CNG channels have several properties that
make them excellent cAMP sensors (Rich et al., 2000).
These properties include their location at the plasma
membrane, rapid gating kinetics, and lack of desensiti-
zation. Furthermore, these channels appear to colocal-
ize with AC in discrete regions of the membrane, which
allows the measurement of localized cAMP signals
(Rich et al., 2000). However, there are several limita-
tions to the use of WT CNG channels to detect changes
in cAMP. First, WT channels have a low apparent afﬁn-
ity for cAMP (Table II and Fig. 2 A), which makes it dif-
ﬁcult to detect the low cAMP concentrations that acti-
vate PKA. Second, these channels are activated more
readily by cGMP than cAMP (Fig. 2 A; see also Dhallan
et al., 1990). Third, they can also be activated directly
by nitric oxide (NO; Broillet, 2000). Fourth, the bind-
ing of the Ca2 –CaM complex to these channels
strongly inhibits channel opening (Liu et al., 1994). To
overcome these limitations, we have modiﬁed the prop-
erties of the WT channel.
Figure 1. Measurement of Ca2  inﬂux through CNG channels in
response to a rise in cAMP. Ca2  inﬂux causes a decrease in ﬂuores-
cence ( F), which was expressed relative to the prestimulus ﬂuores-
cence (F0). In this experiment, HEK-293 cells expressing C460W/
E583M CNG channels responded to increased cAMP levels caused
by exposure to 50 nM rolipram (a PDE type-IV–speciﬁc inhibitor)
added at 0 s (ﬁrst arrow) and 0.5  M forskolin added at 180 s (sec-
ond arrow). After a brief lag,  F changed in a linear fashion (slope
  6.2   10 4 s 1). Slopes were used to assess relative Ca2  inﬂux
rates, for estimating the KI of PDE inhibitors (see Eqs. 2 and 3).
TABLE II
Characteristics of CNG Channels Used as cAMP Sensors
Membrane potential K1/2
cAMP NcAMP K1/2
cGMP NcGMP Imax
cGMP/Imax
cAMP
mV  M  M
WT  50  36   5 2.2   0.1 1.6   0.1 2.3   0.1 1.0
E583M 10.5   0.2 2.4   0.2  28   2 2.4   0.2 0.40   0.10
C460W/E583M 1.2   0.3 2.7   0.2  12   2 2.8   0.3 0.84   0.10
 61-90/C460W/E583M 14.5   1.8 2.1   0.1  36   4 1.8   0.2 0.16   0.08
WT  50  36   5 2.2   0.1 1.3   0.4 2.5   0.4 1.0
E583M  9   2 2.2   0.1  32   4 1.9   0.2 0.35   0.16
C460W/E583M 0.89   0.23 2.2   0.3 6.2   1 2.7   0.1 0.50   0.10
 61-90/C460W/E583M 10.5   0.1 2.2   0.1  16   1 2.6   0.2 0.09   0.06
Data are presented as mean   SD of three experiments. Hill equation parameters are defined in materials and methods. Imax
cGMP/Imax
cAMP is the cur-
rent induced by saturating cGMP divided by the current induced by saturating cAMP.67 Rich et al. 
We ﬁrst introduced the mutation E583M into the rat
olfactory CNG channel   subunit, guided by the work
of Varnum et al. (1995). They showed that mutation of
the corresponding residue in the   subunit of the bo-
vine retinal rod CNG channel (D604M) increased the
sensitivity to cAMP and decreased the sensitivity to
cGMP. The olfactory channel has a higher overall sensi-
tivity to cyclic nucleotides than the rod channel, and, in
excised patches, the E583M channel displayed in-
creased sensitivity for cAMP and decreased sensitivity
for cGMP (Table II; compare Fig. 2, panel A with B).
Furthermore, cGMP was only a partial agonist of the
E583M channel. The current elicited by saturating
cGMP was  40% of the current elicited by saturating
cAMP (Table II and Fig. 2 B).
To further increase the sensitivity to cAMP, we con-
structed a second mutant, C460W/E583M, guided by
studies showing that modiﬁcations to C460 (or C481 in
the retinal channel) increased the sensitivity of CNG
channels to cyclic nucleotides (Finn et al., 1995; Gor-
don et al., 1997; Brown et al., 1998; Zong et al., 1998)
and eliminated sensitivity to NO (Broillet, 2000). The
double mutant was considerably more sensitive to
cAMP than was the E583M channel ( 10-fold lower
 K1/2, Table II and Fig. 2 C).
To remove regulation of the channel by Ca2 -CaM
binding, we deleted residues 61–90, described previ-
ously by Liu et al. (1994). This channel,  61–90/
C460W/E583M, is almost as sensitive to cAMP as the
E583M channel (Table II and Fig. 2 D), yet it is virtually
insensitive to cGMP. In fact, the current elicited by satu-
rating cGMP was  20% of the current elicited by satu-
rating cAMP (Table II and Fig. 2 D). Thus, we have gen-
erated two very useful channel constructs for the
measurement of cAMP: the  61–90/C460W/E583M
channel that is sensitive to cAMP at the upper end of
the physiological range ( 1–50  M), and the C460W/
E583M channel that is sensitive to cAMP at the lower
end of the physiological range ( 0.1–5  M).
Assessment of the Relative cAMP Sensitivity of Channel 
Constructs In Vivo
We next wished to assess the ability of each channel
construct to detect increases in local cAMP concentra-
tion. Changes in cAMP concentration were detected us-
ing fura-2 to monitor Ca2  inﬂux through CNG chan-
nels (see materials and methods for details). We
measured Ca2  inﬂux induced by different concentra-
tions of forskolin, an AC activator, in the presence of
100  M IBMX, a nonselective PDE inhibitor. This ap-
proach allowed us to compare the cAMP sensitivities of
the different channels to changes in cAMP, regardless
of variations in expression levels between experiments.
In HEK-293 cells expressing the WT channel, addition
of forskolin was followed by a brief delay and an in-
crease in Ca2  inﬂux (Fig. 3 A). The delay decreased
and the rate of Ca2  inﬂux increased in a dose-depen-
dent manner. Neither effect was saturated at 50  M for-
skolin. In cells expressing the E583M channel, addition
of forskolin was also followed by a brief delay and an in-
Figure 2. Comparison of CNG channel constructs. Dose–response
relations of   subunit homomultimers of WT (A), E583M (B),
C460W/E583M (C), and  61–90/C460W/E583M (D) rat olfac-
tory CNG channels for cAMP (squares) and cGMP (triangles),
evaluated at a membrane potential of  50 mV. The modiﬁed CNG
channels are more sensitive to cAMP than WT channels, and less
sensitive to cGMP. Solid lines are ﬁts to the Hill equation. For the
experiments shown, K1/2
cAMP   30, 10.3, 1.4, and 15  M;
K1/2
cGMP    1.6, 25, 11, and 36  M, for WT, E583M, C460W/
E583M, and  61–90/C460W/E583M channels, respectively. Other
ﬁt parameters are given in Table II.68 PDE Activity Monitored Using CNG Channels as cAMP Biosensors
crease in Ca2  inﬂux (Fig. 3 B). As with the WT chan-
nel, the delay and the initial rate of Ca2  inﬂux were
dose-dependent. However, both effects saturated at 20
 M forskolin (the 20- and 50- M forskolin traces over-
lap; Fig. 3 B). In cells expressing the C460W/E583M
channel, both the delay and the rate of Ca2  inﬂux
were saturated at 5  M forskolin (Fig. 3 C). In cells ex-
pressing the  61–90/C460W/E583M channel, addi-
tion of forskolin caused similar increases in Ca2  inﬂux
as the E583M channel, including saturation of the de-
lay and rate of inﬂux at 20  M (Fig. 3, compare B and
D). The increased response of the modiﬁed channels
to forskolin treatment is consistent with the apparent
cAMP afﬁnities measured in excised patches in the ab-
sence of Ca2 -CaM (C460W/E583M   E583M    61–
90/C460W/E583M   WT channels). There are several
factors that may have contributed to the apparent lack
of a Ca2 -CaM effect on the channels. As pointed out in
materials and methods, the concentrations of fura-2
being used are likely overwhelming high afﬁnity cellu-
lar Ca2  buffers, in terms of the fraction of incoming
Ca2  that is bound and, therefore, fura-2 is probably
signiﬁcantly reducing the effects of Ca2 -CaM. It is also
possible that HEK-293 cells do not produce enough
CaM to regulate heterologously expressed CNG chan-
nels, or that the CaM concentration within micro-
domains is too low to signiﬁcantly regulate the chan-
nels. Very small forskolin-induced changes in Ca2  in-
ﬂux were observed in HEK-293 cells not expressing
CNG channel constructs (Fig. 4).
PDE Activity in HEK-293 Cells
As described earlier, CNG channels monitor cAMP pro-
duced in subcellular compartments near the plasma
membrane. To assess the extent to which PDE activity af-
fects cAMP levels, we measured forskolin-induced Ca2 
inﬂux in the presence and absence of PDE inhibitors.
Initially we examined the effects of the nonselective PDE
Figure 3. Forskolin-induced cAMP accumulation in HEK-293
cells monitored using Ca2  inﬂux through expressed CNG chan-
nels. 100  M IBMX was added at time zero and different forskolin
concentrations were added at 180 s (indicated by the arrows); con-
centrations (in micromolars) are indicated at the end of each trace.
(A) Forskolin-induced Ca2  inﬂux was observed in cells expressing
the WT channel; the cAMP response (slope) did not saturate in the
forskolin range tested (0–50  M). (B) Forskolin-induced Ca2  in-
ﬂux was larger in cells expressing the E583M channel. More impor-
tantly, the responses saturated at 20  M. (C) Forskolin-induced re-
sponses in cells expressing the C460W/E583M channel saturated at
a lower forskolin concentration, 5  M. (D) Forskolin-induced re-
sponses in cells expressing the  61–90/C460W/E583M channel
were similar to those in cells expressing the E583M channel, satu-
rating at 20  M. For each construct, the variability in the response
between batches of cells was  25% (n   4).
Figure 4. Typical forskolin-induced Ca2  inﬂux in control HEK-
293 cells. HEK-293 cells not expressing CNG channel constructs
were treated in the same manner as those in Fig. 3. Forskolin (0,
0.5, 5, or 50  M) was added 180 s after treatment with 100  M
IBMX. As expected, little or no Ca2  inﬂux was observed in con-
trol HEK-293 cells under any of the experimental conditions de-
scribed in this paper.69 Rich et al. 
inhibitor, IBMX, using each CNG channel construct as a
cAMP sensor. In cells expressing the WT channel, there
was little or no change in Ca2  inﬂux in response to an
intermediate forskolin concentration (10  M; Fig. 5 A).
After a 3-min pretreatment with 100  M IBMX only a
modest forskolin-induced increase in Ca2  inﬂux was ob-
served (Fig. 5 A), arising from Ca2  entry through WT
channels. In cells expressing the E583M channel, a mod-
erate forskolin-induced increase in Ca2  inﬂux was ob-
served in the absence of PDE inhibitors (Fig. 5 B). After
pretreatment with IBMX, forskolin caused a robust in-
crease in Ca2  inﬂux. In cells expressing the C460W/
E583M channel, forskolin-induced increases in Ca2  in-
ﬂux were readily observable, even in the absence of PDE
inhibitors (Fig. 5 C). Thus, this channel is capable of de-
tecting cAMP in cells with low AC activity. Using the
 61–90/C460W/E583M channel as a sensor gave similar
forskolin-induced changes in Ca2  inﬂux as the E583M
channel, both in the absence and presence of IBMX
(Fig. 5, compare B and D). These results demonstrate
that, in HEK-293 cells, basal PDE activity limits the accu-
mulation of cAMP after a moderate stimulus. However,
even in the absence of PDE inhibitors, after stimulation
of AC with high concentrations of forskolin (50–100
 M), cAMP reaches levels high enough to activate WT
CNG channels (not shown).
We next sought to identify pharmacologically the
PDE type(s) that regulates cAMP levels near CNG chan-
nels. The C460W/E583M channels were used to moni-
tor forskolin-stimulated cAMP accumulation in the pres-
ence and absence of a series of PDE inhibitors. The re-
ported IC50 values of inhibitors used in this study for
each PDE type are given in Table I. The PDE inhibitor
concentrations used were typically at least ﬁvefold
higher than the most potent IC50. Either vehicle or PDE
inhibitors were added at 0 s and 1  M forskolin was
added at 180 s (Fig. 6). In the absence of PDE inhibi-
tors, little or no forskolin-induced Ca2  inﬂux was ob-
served; whereas, in the presence of IBMX (10 or 100
 M), or the PDE type-IV–speciﬁc inhibitor RO-20-1724
(10  M) signiﬁcant forskolin-induced Ca2  inﬂux was
observed (Fig. 6, A, B, and G). Two other PDE type-IV
inhibitors signiﬁcantly increased the forskolin-induced
Ca2  inﬂux, rolipram (see Fig. 7 C) and etazolate (not
shown). Inhibitors speciﬁc to other PDE families did
not affect forskolin-induced Ca2  inﬂux. Similar results
were obtained in HEK-293 cells expressing either the
WT or  61–90/C460W/E583M channels by stimulating
cAMP production with higher forskolin concentrations
(10  M, not shown), or when prostaglandin E1 (1  M)
was used to stimulate AC activity (not shown). In these
experiments, we used inhibitor concentrations at which
speciﬁc PDE types should be inhibited; however, many
PDE inhibitors are not completely speciﬁc (Table I).
Also, PDE types VIII and IX are insensitive to IBMX as
well as most PDE inhibitors (see references in Table I).
Unfortunately, dipyridamole, the inhibitor to which
they are most sensitive, ﬂuoresces and, as such, cannot
be used in this assay.
Figure 5. PDE activity reduces forskolin-induced Ca2  inﬂux
through CNG channels in HEK-293 cells. Ca2  inﬂux through WT
(A), E583M (B), C460W/E583M (C), and  61–90/C460W/
E583M (D) CNG channels in response to 10  M forskolin (180 s,
indicated by arrow), after a 3-min pretreatment with either vehicle
( IBMX) or 100  M IBMX. Note that a robust forskolin-induced
response was easily monitored in the absence of IBMX using
C460W/E583M channels as cAMP sensors (C).70 PDE Activity Monitored Using CNG Channels as cAMP Biosensors
In Vivo Estimates of PDE Inhibitor KI
To further establish that PDE type IV is responsible for
the observed IBMX-sensitive PDE activity, we estimated
the KI’s (inhibition constants) of IBMX and two PDE
type-IV inhibitors (RO-20-1724 and rolipram) in vivo.
This required developing a quantitative framework to
assess the relationship between cAMP synthesis, hydro-
lysis, and redistribution throughout the cell. Thus, we
adopted the following formalism:
(2)
d cAMP []
dt
----------------------- C
Vmax cAMP [] ⋅
Km 1 I []
KI
------- + 
 cAMP [] + ⋅
------------------------------------------------------------- – kf cAMP [] , ⋅ – =
where C is the steady-state rate of cAMP synthesis by
AC, Vmax is the maximal rate of cAMP hydrolysis, Km is
the Michaelis constant for PDE, and kf is the rate con-
stant of cAMP ﬂux out of the microdomain. To esti-
mate KI for the PDE inhibitors, we made two assump-
tions. First, we assumed that at low levels of AC stimula-
tion and PDE inhibition, the concentration of local
cAMP is low and diffusion of cAMP out of the micro-
domain is negligible. Second, we assumed that cAMP
levels reach steady-state shortly after AC stimulation
(i.e., equal rates of synthesis and hydrolysis). With
these assumptions, Eq. 2 can be simpliﬁed to:
(3) cAMP []
CK m ⋅
Vmax C –
-------------------- 1 I []
KI
------- + 
 . ⋅ =
Figure 6. Effects of different PDE inhibitors on
forskolin-induced Ca2  inﬂux in HEK-293 cells.
C460W/E583M channels were used to monitor
cAMP accumulation in the presence and absence
of PDE inhibitors. PDE inhibitors were added at
time zero, and 1  M forskolin was added at 180 s
(indicated by arrows). The IC50 for each PDE in-
hibitor is given in Table I. Only the nonspeciﬁc
PDE inhibitor IBMX (A and B) and the PDE type-
IV–speciﬁc inhibitor RO-20-1724 (G) inﬂuenced
the time course of forskolin-induced Ca2  inﬂux.
In general, there was little variability in responses
within a single batch of cells.71 Rich et al. 
Interestingly, this equation reveals that when the inhibi-
tor concentration is equal to KI the cAMP concentration
is twice that in the absence of inhibitor. At low cAMP
concentrations ( K1/2 for the channel), the cAMP con-
centration is proportional to the square root of the Ca2 
inﬂux rate (the Hill coefﬁcient for channel activation is
 2). Thus, KI can be estimated using a linear ﬁt to the
square root of the slopes of the ﬂuorescence traces as a
function of inhibitor concentration (Fig. 7).
The high cAMP afﬁnity C460W/E583M channels
were used to detect changes in cAMP concentration af-
ter pretreatment with PDE inhibitors (added at 0 s) and
modest forskolin stimulation (0.5  M added at 180 s).
IBMX, RO-20-1724, and rolipram were completely
equilibrated across the plasma membrane of HEK-293
cells in  180 s (data not shown). The assumption that
cAMP levels reach steady state is supported by the long-
lasting linear rise in Ca2  concentration after forskolin
stimulation (a steady Ca2  inﬂux rate reﬂects a constant
cAMP level; Fig. 1). Dose–response relations for the
three PDE inhibitors are shown in Fig. 7. Based upon
ﬁts to this data with Eq. 3 (Fig. 7, A–C, insets), the KI val-
ues were estimated to be 11   2  M (IBMX), 0.13  
0.02  M (RO-20-1724), and 0.07   0.02  M (rolipram),
n   4, which are consistent with published IC50 values
from in vitro experiments (Table I). To ensure that the
results were independent of channel construct, we also
estimated the KI for RO-20-1724 using the lower cAMP
afﬁnity  61–90/C460W/E583M channels. The KI (0.15  
0.02  M, n   3) was indistinguishable from that esti-
mated using C460W/E583M channels. These data strongly
suggest that PDE type IV is primarily responsible for the
IBMX-sensitive component of PDE activity monitored
using CNG channels and, thus, for regulating localized
cAMP concentration in HEK-293 cells.
At higher PDE inhibitor concentrations, the square
root of Ca2  inﬂux rate, which is proportional to cAMP
concentration, deviates from linearity (Fig. 7). It is
likely that at higher inhibitor concentrations cAMP
may reach levels  K1/2 of the channel. At these concen-
trations, the relationship between Ca2  inﬂux rate and
cAMP concentration deviates from a simple square law.
Importantly, this does not explain why at high levels of
PDE inhibition the Ca2  inﬂux rate reaches a plateau.
When PDE activity is completely inhibited, forskolin-
stimulated cAMP accumulation would continually in-
crease in a conﬁned region of free diffusion. This, in
turn, would lead to higher Ca2  inﬂux rates. To ensure
that the plateau was not primarily due to channel satu-
ration or Ca2  homeostatic mechanisms, we measured
Ca2  inﬂux rates induced by 50  M forskolin and maxi-
mal PDE inhibition in the same experiment. Under
these conditions, the Ca2  inﬂux rate greatly exceeded
the inﬂux rates induced by 0.5  M forskolin with PDE
inhibition. At increased cAMP concentrations, cAMP
efﬂux from the microdomain is expected to increase;
this increased efﬂux could create the observed plateau.
This would be consistent with the diffusionally re-
stricted microdomain model (Rich et al., 2000).
PDE Activity in GH4C1 Cells
To further test the utility of this approach, we have ex-
amined PDE activity in excitable GH4C1 pituitary cells.
In all the experiments shown (Figs. 8–9 and Table III),
Figure 7. Estimates of KI for three different PDE inhibitors re-
veal that PDE type IV regulates local cAMP levels in HEK-293 cells.
C460W/E583M channels were used to monitor cAMP accumula-
tion triggered by 0.5  M forskolin (180 s) in the presence and ab-
sence of PDE inhibitors (0 s). d( F/F0)/dt was determined as in
Fig. 1. The linear ﬁts used to estimate KI values are shown in the in-
sets (see results for explanation). The KI’s of the PDE inhibitors
were 10  M (IBMX), 0.14  M (RO-20-1724), and 0.09  M (roli-
pram) for the experiments shown.72 PDE Activity Monitored Using CNG Channels as cAMP Biosensors
Figure 8. Detection of AC
and PDE activity in GH4C1
cells. (A) GH4C1 cells ex-
pressing WT CNG channels.
Either 100  M IBMX or vehi-
cle ( IBMX) was added at
time zero. 50  M forskolin
was added at 180 s. (B) Con-
trol cells (not expressing
CNG channels). No forskolin-
induced Ca2  inﬂux was ob-
served under these condi-
tions, or any of the experi-
mental conditions presented.
(C and D) GH4C1 cells
expressing C460W/E583M
channels. IBMX or vehicle
was added at 60 s (ﬁrst ar-
row). Either 10  M forskolin
(C) or 100 nM VIP (D) was
added at 240 s (second ar-
row). In the absence of
IBMX, large forskolin- or VIP-
induced increases in Ca2  in-
ﬂux were observed. When the
local PDE activity was inhib-
ited by 100  M IBMX, sub-
stantial basal AC activity was
revealed. This level of basal
AC activity was quite different
from that observed in HEK-
293 cells (see Figs. 5 and 6). 1
 M nimodipine was added at
time 0 to block endogenous
voltage-gated Ca2  channels.
Figure 9. Evidence that PDE type IV is responsi-
ble for localized, high Km PDE activity in GH4C1
cells.   61–90/C460W/E583M channels were
used to detect changes in cAMP accumulation in
the presence and absence of PDE inhibitors. In-
hibitors were added at 60 s and 10  M forskolin
was added at 240 s. 1  M nimodipine was added
at time zero to block voltage-gated Ca2  channels.
The nonspeciﬁc PDE inhibitor IBMX (A), the
PDE type-I–speciﬁc inhibitor 8-methoxymethyl-
IBMX (8-MM-IBMX, B), and the PDE type-IV–
speciﬁc inhibitors RO-20-1724 (C) and rolipram
(D) increased forskolin-induced Ca2  inﬂux
through CNG channels.73 Rich et al. 
1  M nimodipine was added at time zero to block Ca2 
inﬂux though voltage-gated Ca2  channels (triggered
by membrane depolarization due to Ca2  and Na  in-
ﬂux through CNG channels). This concentration of ni-
modipine was sufﬁcient to block Ca2  inﬂux through
voltage-gated Ca2  channels activated by membrane de-
polarization in 24 mM external KCl, and did not alter
forskolin or pCPT-cGMP induced Ca2  inﬂux through
CNG channels expressed in HEK-293 cells (data not
shown). Figs. 8–9 each depict experiments done on a
single batch of cells. As before, similar results were ob-
tained on three other batches.
Fig. 8 A shows the forskolin-induced responses of
cells expressing WT channels. Either vehicle or 100  M
IBMX was added at 0 s and 50  M forskolin was added
at 180 s. After the addition of forskolin, there was a
short delay followed by an increased Ca2  inﬂux. The
slope of the Ca2  inﬂux was greater in the presence of
IBMX, indicating higher cAMP levels. In control cells
(cells not expressing CNG channel constructs), no for-
skolin-induced Ca2  inﬂux was observed in either the
presence or absence of IBMX (Fig. 8 B). This was true
of controls done for all experimental protocols.
We next examined forskolin-induced responses and
the effects of IBMX in cells expressing the high cAMP
afﬁnity construct, C460W/E583M. In these experi-
ments, either vehicle or 100  M IBMX was added at 60 s
(Fig. 8, C and D). Interestingly, the addition of IBMX
triggered Ca2  inﬂux that was not observed in either
control cells or cells expressing the WT channel. Subse-
quent addition of 10  M forskolin (Fig. 8 C) or 100 nM
vasoactive intestinal peptide (VIP; Fig. 8D) caused addi-
tional cAMP accumulation and Ca2  inﬂux. A compari-
son of responses measured with the WT and C460W/
E583M channels indicates that the IBMX-induced re-
sponse was not due to an increase in local cGMP con-
centration. Moreover, 100  M IBMX did not alter CNG
channel activity monitored in excised patches (data not
shown). Thus, these data indicate that the IBMX-
induced Ca2  inﬂux was due primarily to an increase in
cAMP arising from basal AC activity.
To identify the PDE family or families that regulate
the local cAMP concentration in GH4C1 cells, cAMP
accumulation was monitored in the presence and ab-
sence of PDE inhibitors (Table III). Again, the high
cAMP afﬁnity C460W/E583M channels were used. PDE
inhibitors were added at 60 s. Although the addition of
IBMX alone triggered Ca2  inﬂux, we added 10  M
forskolin at 240 s as a positive control for CNG channel
activity. Only the nonspeciﬁc PDE inhibitor, IBMX, and
the PDE type-I–speciﬁc inhibitor, 8-methoxymethyl-
IBMX, induced Ca2  inﬂux through CNG channels
(Table III). This PDE is likely to have a low Km for
cAMP because it is capable of regulating cAMP at con-
centrations too low for the WT or  61–90/C460W/
E583M channels to detect. Thus, it is likely that a Ca2 -
CaM–stimulated PDE (type I) is primarily responsible
for controlling basal cAMP signals in GH4C1 cells.
We also monitored PDE activity using  61–90/
C460W/E583M channels to detect changes in cAMP
concentration (Fig. 9). PDE inhibitors and forskolin
were added as described above. With this construct, we
were unable to observe changes in cAMP concentration
due to inhibition of PDE activity alone. However, PDE
inhibitors caused an increase in forskolin-induced Ca2 
inﬂux. As observed using the high cAMP afﬁnity
C460W/E583M channels, both IBMX and the PDE
type-I–speciﬁc inhibitor 8-methoxymethyl-IBMX signiﬁ-
cantly inhibited PDE activity (Fig. 9, A and B). Interest-
ingly, the PDE type-IV–speciﬁc inhibitors, RO-20-1724
and rolipram, also inhibited PDE activity (Fig. 9, C and
D). Inhibitors speciﬁc to other PDE types had no effect
on the forskolin-induced Ca2  inﬂux (data not shown).
No RO-20-1724- or rolipram-sensitive PDE was observed
using the high cAMP afﬁnity channel (Table III). It is
likely that Ca2  inﬂux through the C460W/E583M chan-
nels was saturated at cAMP concentrations below the
Km for this PDE. Thus, there are likely two different PDE
types that regulate local cAMP signals in GH4C1 cells: a
low Km, 8-methoxymethyl-IBMX–sensitive PDE (type I) and
a high Km, RO-20-1724-rolipram–sensitive PDE (type IV).
DISCUSSION
We have made several modiﬁcations to the WT rat olfac-
tory CNG channel that signiﬁcantly enhance its utility as
a cAMP sensor. Three novel constructs were tested. The
E583M channel is more sensitive to cAMP and less sensi-
tive to cGMP. Two additional mutations produced chan-
nels that make even better cAMP sensors. The C460W/
E583M channel has a high afﬁnity for cAMP, allowing it
to detect cAMP at levels which activate PKA. The  61–
TABLE III
Effect of PDE Inhibitors on Basal cAMP Levels in GH4C1 Cells
Inhibitor d( F/F0)/dt No. of experiments
 Ms  1
100 IBMX 0.0025   0.0009  5
100 8-methoxymethyl-IBMX 0. 0029   0.0011 4
10 EHNA 0 3
1 Trequinsin 0 3
15 Quazinone 0 3
100 RO-20-1724 0 4
100 Rolipram 0 4
50 Zaprinast 0 3
cAMP concentration was monitored using Ca2  influx through C460W/
E583M channels. The experimental protocol is described in the legend of
Fig. 8 C. d( F/F0)/dt, which is proportional to the Ca2  influx rate, was
estimated as described in materials and methods. Data are given as
mean   standard error.74 PDE Activity Monitored Using CNG Channels as cAMP Biosensors
90/C460W/E583M channel is almost as sensitive to
cAMP as E583M. However, the  61–90/C460W/E583M
channel has two important advantages: it is not inhibited
by Ca2 -CaM, and it is barely activated by cGMP.
Using both WT and modiﬁed CNG channels, we have
developed a convenient assay for detecting changes in
local cAMP concentration, and used this assay to exam-
ine PDE activity in two cell types. There are several ad-
vantages of measuring Ca2  inﬂux through CNG chan-
nels as a way to monitor changes in cAMP. First, this assay
is very simple to implement in either cell populations or
single cells. Second, the measurement has a high signal-
to-noise ratio. Third, it is sensitive to small changes in AC
activity. This is due, in part, to the fact that CNG chan-
nels detect local rather than total cellular cAMP. With
traditional assays, high agonist and PDE inhibitor con-
centrations are often required to detect cAMP accumu-
lation. In contrast, the channels described here readily
detect changes in cAMP caused by subsaturating agonist
concentration in the absence of PDE inhibitors. Overall,
the assay presented here can be used as an initial screen
for changes in cAMP in response to physiological stimuli
or pharmacological agents.
There are a few shortcomings to this approach that
should be mentioned. The temporal resolution is
somewhat limited. It is also difﬁcult to extract the pre-
cise cAMP concentration from this assay because the re-
sponses cannot be calibrated (with known intracellular
cAMP), and because Ca2  handling and depletion of
free fura-2 become issues at high Ca2  inﬂux rates.
When more precise measurements of local cAMP are
required, cAMP concentration can be determined us-
ing electrophysiological methods (Rich et al., 2000). Al-
though such experiments are considerably more difﬁ-
cult, the increased temporal resolution, higher dy-
namic range, and more accurate measurement of
cAMP concentration will be required for a detailed un-
derstanding of cAMP signals.
We have previously demonstrated in HEK-293 and
C6–2B glioma cells that CNG channels measure cAMP
produced in subcellular compartments or micro-
domains near the plasma membrane, and that diffu-
sion of cAMP between the microdomains and the bulk
cytosol is severely hindered (Rich et al., 2000). This
conclusion was based on several lines of evidence. First,
forskolin-induced increases in cAMP concentration
measured using CNG channels ( 25  M) were much
greater than the increases in cAMP concentration aver-
aged throughout the accessible cell volume (1–2  M).
Second, forskolin-induced cAMP accumulation was eas-
ily detected by CNG channels in the rapidly dialyzed,
whole-cell patch-clamp conﬁguration. Third, the wash-
in of cAMP from the patch pipette to the CNG chan-
nels was much slower than would be expected based
upon the rapid exchange of the bulk cytosol. All of
these results were described by a three-compartment
model (microdomain, cytosol, and whole-cell pipette)
in which the transfer rates between compartments were
determined using data from the wash-in experiments.
Much has been learned about the 2-D localization of
proteins involved in cellular signaling. For example,
certain isoforms of PDE are differentially distributed
between particulate (membrane-localized) and super-
natant (cytosolic) cellular fractions; PDE kinetics may
vary with cellular localization (Bolger et al., 1997). Ele-
ments of G-protein signaling pathways have been
shown to preferentially localize within caveolae (dis-
tinct regions of the plasma membrane; Rybin et al.,
2000). In addition, a recent report has described the lo-
calization of different voltage-gated K  channels to dis-
tinct populations of lipid rafts (Martens et al., 2001).
However, 2-D localization within the plasma mem-
brane does not account for the 3-D compartmentaliza-
tion of cAMP signals. We have shown that proximity to
AC does not provide sufﬁcient cAMP concentrations for
activation of effector proteins because, in essence, each
cAMP molecule diffuses away more rapidly than the
next molecule is synthesized (Rich et al., 2000). Thus,
PDE activity alone is unlikely to be responsible for com-
partmentalized cAMP signals because PDE activity only
lowers cAMP levels. It is more likely that PDEs regulat-
ing cAMP levels detected by CNG channels are localized
within the same 3-D compartment as AC and CNG
channels. Importantly, by regulating cAMP concentra-
tion within this compartment, PDE activity affects the
rate of cAMP ﬂux between compartments. This PDE is
likely to be a component of the previously described
particulate PDE fractions. Cytosolic PDE is likely to reg-
ulate cAMP in other cellular compartments.
In the current study, we have used Ca2  inﬂux
through CNG channels to detect changes in cAMP con-
centration in both nonexcitable HEK-293 cells and ex-
citable pituitary GH4C1 cells. The speciﬁc goal was to
assess the PDE subtypes responsible for shaping cAMP
signals near the plasma membrane. To study the effects
of PDEs, it is important to be able to ﬁrst detect cAMP
changes in the absence of PDE inhibitors. We had no
difﬁculty with this in either cell type, despite the modest
levels of cAMP accumulation in response to forskolin or
VIP stimulation reported previously (Mollard et al.,
1992; Fagan et al., 1996, 2000). In HEK-293 cells, only
nonselective and PDE type-IV–selective inhibitors de-
creased PDE activity. The in vivo estimates of KI for
three PDE inhibitors (IBMX, RO-20-1724, and roli-
pram) presented here are consistent with IC50 values es-
timated in vitro for PDE type IV. These data are also
consistent with a previous report that identiﬁed two iso-
forms of PDE type IV (PDE4D3 and PDE4D5) in HEK-
293 cells based on Western blot analysis (Hoffmann et
al., 1999). Inhibition of PDE activity did not reveal basal75 Rich et al. 
AC activity in HEK-293 cells. In GH4C1 cells, inhibitors
selective to PDE types I and IV decreased PDE activity.
Using the high cAMP afﬁnity CNG channels, inhibition
of PDE type I activity led to a rise in local cAMP concen-
tration in the absence of AC stimulation. This increase
revealed substantial basal AC activity in GH4C1 cells.
Under the same conditions, no change in cAMP level
was observed when PDE type-IV inhibitors were added.
However, using the lower cAMP afﬁnity,  61–90/
C460W/E583M channels, inhibition of either PDE type
I or type IV increased forskolin-induced cAMP accumu-
lation. These observations point to the presence of two
different PDE types: a low Km, PDE type I and a higher
Km, PDE type IV. Based on the apparent cAMP afﬁnities
of the two channel constructs, we estimate the two Km
values to be  1  M and  5  M.
Interestingly, the data in GH4C1 cells indicate the
presence of a “futile cycle” of cAMP synthesis and hy-
drolysis. Obviously, restricting this phenomenon to sub-
cellular compartments would be advantageous energet-
ically, but why expend the additional energy at all? One
possibility is that constant AC and PDE activity allow
the system to respond rapidly to a stimulus. In essence,
the enzymes are poised to respond to changes in active
G-protein or changes in internal Ca2 , allowing for
rapid increases or decreases in cAMP levels. A similar
situation exists in light-adapted photoreceptor cells; for
a detailed discussion see Nikonov et al. (2000).
The existence of PDE type I in GH4C1 cells is consis-
tent with previous work showing that CaM antagonists
inhibit the hydrolysis of cAMP (Sletholt et al., 1987).
Furthermore, a high Km (28.6  M) and a low Km (0.66
 M) PDE have been identiﬁed in both GH3 and
GH4C1 cells, each PDE with a different IC50 for the-
ophylline (Gautvik et al., 1982). These Km values are
consistent with our in vivo estimates of the Km values
for PDEs that regulate local cAMP levels. The presence
of both high and low Km PDEs offers two possibilities
for the shaping of cAMP signals: (1) that both PDE
types regulate cAMP levels within a single compart-
ment, or (2) that they differentially regulate cAMP lev-
els in different cellular compartments.
If the two PDE types coexist in the same subcellular
compartment then the low Km PDE would be likely to
regulate cAMP levels under basal conditions. Upon fur-
ther activation of AC, this PDE would be overwhelmed,
and large concentrations of cAMP would accumulate
locally. The high Km PDE would be able to efﬁciently
hydrolyze cAMP at these elevated concentrations. Fur-
thermore, these PDE types could be differentially regu-
lated, allowing different feedback mechanisms to con-
trol cAMP levels within this compartment. If the activity
of the two PDE types is compartmentalized, then dis-
tinct cyclic nucleotide signals could occur simulta-
neously in different regions of the cell. Although this
has not yet been demonstrated, it seems likely because
cAMP can be excluded from areas of the cell by PDE
activity (Jurevicius and Fischmeister, 1996), cAMP is
produced in microdomains with restricted diffusional
access to the bulk cytosol (Rich et al., 2000), and differ-
ent pools of cGMP have different functional effects in
ECV304 epithelial cells (Zolle et al., 2000).
In the future, it should be possible with the improved
sensors to measure local cAMP signals in response to a
variety of extracellular stimuli. The ultimate goal is to
understand how cAMP can differentially regulate  200
cellular targets. This requires a quantitative knowledge
of how cAMP signals are initiated and terminated. Dif-
ferent PDE subtypes are likely to play crucial roles in
shaping the signals in different cellular compartments.
Within these compartments, cAMP levels are likely to
vary dynamically (Brooker, 1973; Cooper et al., 1995,
1998), particularly in excitable cells where Ca2  levels
oscillate during a train of action potentials. For exam-
ple, modulation of PDE type I by Ca2 -CaM in excitable
GH4C1 cells could contribute to transient or oscillating
cAMP signals. In general, dynamic cAMP signals would
escape detection with conventional techniques.
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